About Event

Welcome to the Most Comprehensive Forum for Microbiome Drug Developers

As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th year - is evolving to showcase these new studies.

This year’s conference will focus more on new technological innovations, manufacturing challenges, and showcasing pivotal new data. That said, we are still dedicated to providing foundational science and pre-clinical insights so that this event offers valuable learnings from everyone in the microbiome therapeutics space – no matter what stage of development they are at.

Now, the community must gather to:

Improve understanding of the mechanistic function of the microbiome, focusing on outlining specific modes of action of live biotherapeutic and small molecule approaches 

Optimize clinical outcomes with improved trial design and leveraging previous successes, as well as through stratifying patients through clinically relevant biomarkers 

Achieve a consistent production supply, with purity and scalability at the forefront of our minds to address the growing production demands 

 

Agenda at a Glance

4 Areas that Define the Drug Development Summit

Join us Back Face to Face

Brand New Double Streamed Pre-Conference Day

Five Panel Discussions

Big Pharma Representation

Hear What the Microbiome Community Says

"By bringing together experts in the field who are approaching this challenge from
every angle, we can synergistically accelerate unleashing the complete therapeutic
power of the microbiome

Emily Drabant Conley, Federation Bio

I am excited about the opportunity to discuss openly with key stakeholders in our field the next frontiers we collectively see and the most critical challenges we face in translating our research to the clinic

Stephanie Culler, Persephone Biosciences